160 Health International Limited announced that, during the period from January 2025 to 31 March 2026, its “160AI Hospital” operational collaboration model added 20 new public medical partners, bringing the cumulative total to 102 institutions.

Among these partners, 54 are Class IIIA hospitals—accounting for 52.9% of the total—while 78 (76.5%) are Class III or above, underscoring deep penetration into China’s top-tier medical system.

The collective scale of the partner hospitals is substantial. On an aggregated basis, they handle approximately 84.37 million outpatient visits per year and generate around RMB 99.70 billion in annual revenue, providing a sizeable platform for 160 Health’s digital healthcare and wellness solutions.

Management highlighted that the “160AI Hospital” model, initially piloted and now deployed at scale, is being reinforced by the rollout of a “Medical Digital Staff” system to further integrate AI-driven services within clinical settings. The company aims to expand hospital coverage nationwide while deepening product offerings to support the digital transformation of China’s healthcare sector.

The Board reiterated that the disclosed metrics relate solely to specific business segments; overall performance and future developments remain subject to market conditions, regulatory changes and implementation progress.